ATE384738T1 - Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen - Google Patents

Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen

Info

Publication number
ATE384738T1
ATE384738T1 AT99960752T AT99960752T ATE384738T1 AT E384738 T1 ATE384738 T1 AT E384738T1 AT 99960752 T AT99960752 T AT 99960752T AT 99960752 T AT99960752 T AT 99960752T AT E384738 T1 ATE384738 T1 AT E384738T1
Authority
AT
Austria
Prior art keywords
dna fragments
chlamydia
corresponding dna
chlamydia antigens
atp
Prior art date
Application number
AT99960752T
Other languages
English (en)
Inventor
Andrew Murdin
Raymond Oomen
Joe Wang
Pamela Dunn
Original Assignee
Aventis Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur filed Critical Aventis Pasteur
Application granted granted Critical
Publication of ATE384738T1 publication Critical patent/ATE384738T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
AT99960752T 1998-12-28 1999-12-22 Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen ATE384738T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11406098P 1998-12-28 1998-12-28
US12396799P 1999-03-12 1999-03-12
US14127199P 1999-06-30 1999-06-30

Publications (1)

Publication Number Publication Date
ATE384738T1 true ATE384738T1 (de) 2008-02-15

Family

ID=27381435

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99960752T ATE384738T1 (de) 1998-12-28 1999-12-22 Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen

Country Status (10)

Country Link
US (1) US20020081682A1 (de)
EP (1) EP1140998B1 (de)
JP (1) JP2002541766A (de)
AT (1) ATE384738T1 (de)
AU (1) AU774902B2 (de)
CA (1) CA2356057A1 (de)
DE (1) DE69938059T2 (de)
MX (1) MXPA01006663A (de)
NZ (1) NZ512448A (de)
WO (1) WO2000039157A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169465B1 (de) * 1998-12-04 2006-03-01 University Of Manitoba Zwei-schritte-verfahren zur impfung gegen chlamydia
AU1375501A (en) * 1999-11-12 2001-05-30 Aventis Pasteur Limited Chlamydia antigens and corresponding DNA fragments and uses thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE312920T1 (de) * 1996-07-12 2005-12-15 Dna immunisierung gegen chlamydia infektion
JP2002536958A (ja) * 1997-11-21 2002-11-05 ジェンセット Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅゲノム配列およびポリペプチド、それらのフラグメント、ならびに特に感染症の診断、予防および治療のためのそれらの使用
EP2218731A1 (de) 1997-11-28 2010-08-18 Merck Serono Biodevelopment Genomsequenz von Chlamydia trachomatis sowie Polypeptide, Fragmente davon und deren Verwendung, insbesondere zur Diagnose, Prävention und Behandlung einer Infektion
CA2350775A1 (en) 1998-11-12 2000-05-18 The Regents Of The University Of California Chlamydia pneumoniae genome sequence
JP2002531129A (ja) 1998-12-08 2002-09-24 コリクサ コーポレイション クラミジア感染の処置および診断のための化合物および方法
US6565856B1 (en) 1998-12-08 2003-05-20 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
US20020061848A1 (en) 2000-07-20 2002-05-23 Ajay Bhatia Compounds and methods for treatment and diagnosis of chlamydial infection
GB9828000D0 (en) 1998-12-18 1999-02-10 Chiron Spa Antigens
GB9902555D0 (en) 1999-02-05 1999-03-24 Neutec Pharma Plc Medicament
DE60036698T2 (de) 1999-05-03 2008-07-24 Sanofi Pasteur Ltd., Toronto Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
NZ517952A (en) 1999-09-20 2004-01-30 Aventis Pasteur Chlamydia antigens and corresponding DNA fragments and uses thereof
US6632663B1 (en) 1999-09-22 2003-10-14 Aventis Pasteur Limited DNA immunization against chlamydia infection
EP1240331B1 (de) 1999-12-22 2010-04-07 Aventis Pasteur Limited Chlamydia antigene, entsprechende dns fragmente und ihre verwendungen
WO2001081379A2 (en) 2000-04-21 2001-11-01 Corixa Corporation Compounds and methods for treatment and diagnosis of chlamydial infection
AU2001258105A1 (en) 2000-05-08 2001-11-20 Aventis Pasteur Limited Chlamydia antigens and corresponding dna fragments and uses thereof
JP2004502415A (ja) 2000-07-03 2004-01-29 カイロン　エセ．ピー．アー． Ｃｈｌａｍｙｄｉａｐｎｅｕｍｏｎｉａｅに対する免疫化

Also Published As

Publication number Publication date
AU1765200A (en) 2000-07-31
WO2000039157A1 (en) 2000-07-06
AU774902B2 (en) 2004-07-15
EP1140998A1 (de) 2001-10-10
DE69938059T2 (de) 2009-01-08
DE69938059D1 (de) 2008-03-13
EP1140998B1 (de) 2008-01-23
JP2002541766A (ja) 2002-12-10
CA2356057A1 (en) 2000-07-06
MXPA01006663A (es) 2005-08-26
NZ512448A (en) 2004-01-30
US20020081682A1 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
WO2000066739A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001046224A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
BR9712971A (pt) Método para produção de uma vacina para proteção de um hospedeiro contra doença causada com uma cadeia de chlamydia e composição imunológica
CL2009000575A1 (es) Anticuerpos aislados anti-interleuquina 12 (anti il-12) de mamiferos, secuencia de nucleotidos, vector, celula y metodo de produccion, composicion y dispositivo medico que contienen, util en el diagnostico y tratamiento de condicones relacionadas con il-12.
DE69636017D1 (de) Pneumokokkengene, ihre fragmente, ihre expressionsprodukte und die verwendung der gene, fragmente und produkte
CY1118443T1 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοι και χρησεις
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
ATE352638T1 (de) REVERSE ßTWO-HYBRIDß-SYSTEME
ATE211174T1 (de) Thymidin-kinase-mutanten
ATE384793T1 (de) Chlamydia antigene und entsprechende dna- fragmente und ihre verwendungen
DE69840333D1 (de) 2-m übergang des zellzyklus
TR200002989T2 (tr) Heliomisin için gen kodu ve bunun kullanılması.
WO2001046225A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2001075111A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
WO2002040668A3 (de) Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen
WO2001075112A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ATE417106T1 (de) Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon
WO2001074863A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
FR2710074B1 (fr) Gène GRB3-3, ses variants et leurs utilisations.
WO2001046226A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ATE384738T1 (de) Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen
WO2000006742A3 (en) Chlamydia antigens and corresponding dna fragments and uses thereof
ATE420106T1 (de) Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung
MXPA01004353A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.
MXPA01001639A (es) Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1140998

Country of ref document: EP